Skip to main content
PMC home page
Gut logoLink to Gut
. 1995 Jul;37(1):71–76. doi: 10.1136/gut.37.1.71

A controlled study of bone mineral density in patients with inflammatory bowel disease.

J A Silvennoinen 1, T J Karttunen 1, S E Niemelä 1, J J Manelius 1, J K Lehtola 1
PMCID: PMC1382771  PMID: 7672685

Abstract

To assess the prevalence of and risk factors for low bone mineral density in inflammatory bowel disease (IBD), 152 IBD patients and 73 healthy controls were studied. Sixty seven patients had ulcerative colitis, 78 had Crohn's disease (52 of them (66.7%) had ileal disease), and seven had indeterminate colitis. Bone mineral density values (g/cm2) measured by dual energy x ray absorbtiometry at the spine (L2-L4), the femoral neck, Ward's triangle, and the trochanter were 1.177, 0.948, 0.850, and 0.838 in the patients and 1.228 (p = 0.034), 1.001 (p = 0.009), 0.889 (NS), and 0.888 (p = 0.012) in the control group, respectively. The type or extent of the disease or previous small bowel resection did not have any significant effect on the bone mineral density values. There was a weak, but statistically significant negative correlation between bone mineral density and the total lifetime corticosteroid dose (in the lumbar spine r = -0.164, p = 0.04, the femoral neck r = -0.185, p = 0.02, Ward's triangle r = -0.167, p = 0.04, and the trochanter r = -0.237, p = 0.003). The patients whose lifetime corticosteroid dose (prednisone/prednisolone) was more than 10 g had especially low bone mineral density (p < 0.05 compared with the groups with no or less than 5 g of corticosteroid). The patients who had never taken peroral corticosteroids did not have decreased bone mineral density. In conclusion, IBD patients have significantly lower bone mineral density values than healthy controls, but the difference is not so great as has been reported previously. Low bone mineral density values in these patients are related to high lifetime corticosteroid doses.

Full text

PDF
71

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson R., Rundgren A., Rosengren K., Bengtsson B. A., Malmvall B. E., Mellström D. Osteoporosis after long-term corticosteroid treatment of giant cell arteritis. J Intern Med. 1990 Jun;227(6):391–395. doi: 10.1111/j.1365-2796.1990.tb00177.x. [DOI] [PubMed] [Google Scholar]
  2. Bartley J. J., Jr Crohn's disease. History and case report of associated metatarsal stress fracture. J Am Podiatr Med Assoc. 1989 Feb;79(2):82–83. doi: 10.7547/87507315-79-2-82. [DOI] [PubMed] [Google Scholar]
  3. Binder V., Both H., Hansen P. K., Hendriksen C., Kreiner S., Torp-Pedersen K. Incidence and prevalence of ulcerative colitis and Crohn's disease in the County of Copenhagen, 1962 to 1978. Gastroenterology. 1982 Sep;83(3):563–568. [PubMed] [Google Scholar]
  4. Binder V., Hendriksen C., Kreiner S. Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen. Gut. 1985 Feb;26(2):146–150. doi: 10.1136/gut.26.2.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chong S. K., Blackshaw A. J., Boyle S., Williams C. B., Walker-Smith J. A. Histological diagnosis of chronic inflammatory bowel disease in childhood. Gut. 1985 Jan;26(1):55–59. doi: 10.1136/gut.26.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Clements D., Motley R. J., Evans W. D., Harries A. D., Rhodes J., Coles R. J., Compston J. E. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol. 1992 Dec;27(12):1055–1060. doi: 10.3109/00365529209028138. [DOI] [PubMed] [Google Scholar]
  7. Compston J. E., Creamer B. Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut. 1977 Mar;18(3):171–175. doi: 10.1136/gut.18.3.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Compston J. E., Judd D., Crawley E. O., Evans W. D., Evans C., Church H. A., Reid E. M., Rhodes J. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987 Apr;28(4):410–415. doi: 10.1136/gut.28.4.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cummings S. R., Black D. M., Nevitt M. C., Browner W., Cauley J., Ensrud K., Genant H. K., Palermo L., Scott J., Vogt T. M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993 Jan 9;341(8837):72–75. doi: 10.1016/0140-6736(93)92555-8. [DOI] [PubMed] [Google Scholar]
  10. Declercq S. S., Meredith P. C., Rosenthal A. R. Experimental siderosis in the rabbit: correlation between electroretinography and histopathology. Arch Ophthalmol. 1977 Jun;95(6):1051–1058. doi: 10.1001/archopht.1977.04450060138014. [DOI] [PubMed] [Google Scholar]
  11. Farthing M. J., Dawson A. M. Impaired semen quality in Crohn's disease--drugs, ill health, or undernutrition? Scand J Gastroenterol. 1983 Jan;18(1):57–60. doi: 10.3109/00365528309181559. [DOI] [PubMed] [Google Scholar]
  12. Hahn T. J., Boisseau V. C., Avioli L. V. Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass. J Clin Endocrinol Metab. 1974 Aug;39(2):274–282. doi: 10.1210/jcem-39-2-274. [DOI] [PubMed] [Google Scholar]
  13. Harries A. D., Brown R., Heatley R. V., Williams L. A., Woodhead S., Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut. 1985 Nov;26(11):1197–1203. doi: 10.1136/gut.26.11.1197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hui S. L., Slemenda C. W., Johnston C. C., Jr Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 1989 Sep 1;111(5):355–361. doi: 10.7326/0003-4819-111-5-355. [DOI] [PubMed] [Google Scholar]
  15. Hylander E., Ladefoged K., Jarnum S. The importance of the colon in calcium absorption following small-intestinal resection. Scand J Gastroenterol. 1980;15(1):55–60. doi: 10.3109/00365528009181432. [DOI] [PubMed] [Google Scholar]
  16. Kröger H., Heikkinen J., Laitinen K., Kotaniemi A. Dual-energy X-ray absorptiometry in normal women: a cross-sectional study of 717 Finnish volunteers. Osteoporos Int. 1992 May;2(3):135–140. doi: 10.1007/BF01623820. [DOI] [PubMed] [Google Scholar]
  17. Kröger H., Laitinen K. Bone mineral density measured by dual-energy X-ray absorptiometry in normal men. Eur J Clin Invest. 1992 Jul;22(7):454–460. doi: 10.1111/j.1365-2362.1992.tb01490.x. [DOI] [PubMed] [Google Scholar]
  18. Lindberg E., Jörnerot G. The incidence of Crohn's disease is not decreasing in Sweden. Scand J Gastroenterol. 1991 May;26(5):495–500. doi: 10.3109/00365529108998572. [DOI] [PubMed] [Google Scholar]
  19. Mazess R. B., Barden H. S. Measurement of bone by dual-photon absorptiometry (DPA) and dual-energy X-ray absorptiometry (DEXA). Ann Chir Gynaecol. 1988;77(5-6):197–203. [PubMed] [Google Scholar]
  20. Motley R. J., Crawley E. O., Evans C., Rhodes J., Compston J. E. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut. 1988 Oct;29(10):1332–1336. doi: 10.1136/gut.29.10.1332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Myren J., Gjone E., Hertzberg J. N., Rygvold O., Semb L. S., Fretheim B. Epidemiology of ulcerative colitis and regional enterocolitis (Crohn's disease) in Norway. Scand J Gastroenterol. 1971;6(6):511–514. doi: 10.3109/00365527109181666. [DOI] [PubMed] [Google Scholar]
  23. Pera A., Bellando P., Caldera D., Ponti V., Astegiano M., Barletti C., David E., Arrigoni A., Rocca G., Verme G. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score. Gastroenterology. 1987 Jan;92(1):181–185. [PubMed] [Google Scholar]
  24. Pigot F., Roux C., Chaussade S., Hardelin D., Pelleter O., Du Puy Montbrun T., Listrat V., Dougados M., Couturier D., Amor B. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci. 1992 Sep;37(9):1396–1403. doi: 10.1007/BF01296010. [DOI] [PubMed] [Google Scholar]
  25. Sambrook P. N., Eisman J. A., Yeates M. G., Pocock N. A., Eberl S., Champion G. D. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis. 1986 Nov;45(11):950–953. doi: 10.1136/ard.45.11.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sitrin M. D., Rosenberg I. H., Chawla K., Meredith S., Sellin J., Rabb J. M., Coe F., Kirsner J. B., Kraft S. C. Nutritional and metabolic complications in a patient with Crohn's disease and ileal resection. Gastroenterology. 1980 May;78(5 Pt 1):1069–1079. [PubMed] [Google Scholar]
  27. Sitrin M., Meredith S., Rosenberg I. H. Vitamin D deficiency and bone disease in gastrointestinal disorders. Arch Intern Med. 1978 May 15;138(Spec No):886–888. [PubMed] [Google Scholar]
  28. Teufel M., Meyer-Hohnloser H., Mörcke E. M., Stubig U., Niessen K. H. Nachuntersuchungen bei 60 Kindern mit Colitis ulcerosa und Morbus Crohn. Monatsschr Kinderheilkd. 1988 Jul;136(7):378–383. [PubMed] [Google Scholar]
  29. Vogelsang H., Ferenci P., Woloszczuk W., Resch H., Herold C., Frotz S., Gangl A. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci. 1989 Jul;34(7):1094–1099. doi: 10.1007/BF01536381. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES